New screening tool could improve the survival rate of patients with hepatocellular carcinoma from 20% to 90%

Early diagnosis of hepatocellular carcinoma (HCC) -- one of the most fatal malignancies -- is crucial to improve patient survival. In a breakthrough study investigators report on the development of a serum fusion-gene machine-learning model. This important screening tool may increase the five-year survival rate of patients with HCC from 20% to 90% because of its improved accuracy in early diagnosis of HCC and monitoring the impact of treatment.

  Health   Jun 17, 2024   0   56  Add to Reading List


Click the link to join the registration on WhatsApp: https://chat.whatsapp.com/KThkuZlWaTcCu3iJHGBmLM


Click the link to join the registration on WhatsApp: https://chat.whatsapp.com/KThkuZlWaTcCu3iJHGBmLM


Click the link to join the registration on WhatsApp: https://chat.whatsapp.com/KThkuZlWaTcCu3iJHGBmLM
Early diagnosis of hepatocellular carcinoma (HCC) -- one of the most fatal malignancies -- is crucial to improve patient survival. In a breakthrough study investigators report on the development of a serum fusion-gene machine-learning model. This important screening tool may increase the five-year survival rate of patients with HCC from 20% to 90% because of its improved accuracy in early diagnosis of HCC and monitoring the impact of treatment.
Read Original   

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow